Oncology

FDA Approves Opdivo for Advanced Renal Cell Carcinoma

FDA · renal cell carcinoma · 5 min

FDA Approves Keytruda for Adjuvant Treatment of Stage III Melanoma

FDA · oncology · 4 min

FDA Approves Imfinzi: Breakthrough for Stage III NSCLC Treatment

FDA · Non-Small Cell Lung Cancer · 4 min

FDA Approval Tarzenta: Accelerated Approval for Advanced HER2-Negative Breast Cancer

FDA · breast cancer · 7 min

FDA Approves Tevimbra: Breakthrough for Esophageal Squamous Cell Carcinoma

FDA · Esophageal Squamous Cell Carcinoma · 5 min

FDA Approves Augtyro: Bristol Myers Squibb’s Repotrectinib for ROS1-NSCLC

FDA · Non-Small Cell Lung Cancer · 4 min

FDA Grants Priority Review to Sotorasib for KRAS G12C NSCLC

FDA · non-small cell lung cancer · 4 min

FDA Approves Bosulif for Pediatric Chronic Myelogenous Leukemia

FDA · chronic myelogenous leukemia · 7 min

FDA Approves Opdivo Plus Chemotherapy for Gastric Cancer

FDA · gastric cancer · 4 min

FDA Approves Breyanzi: Novel CAR-T Therapy for Mantle Cell Lymphoma

FDA · mantle cell lymphoma · 4 min

FDA Approval Mirvetuximab Soravtansine: Accelerated OK for Elahere in Ovarian Cancer

FDA · Ovarian Cancer · 4 min

CAR-T Cell Therapy Advancements and FDA Regulatory Pathways 2024

FDA · Hematologic Malignancies · 10 min